368 results on '"Ozakbas, S"'
Search Results
152. Correlations between auditory consonant trigram test, paced auditory serial addition test health-related quality of life during and after treatment of relapses in patients with clinically isolated syndrome
153. Prediction of conversion from clinically isolated syndrome to multiple sclerosis according to baseline characteristics
154. The comparison of McDonald 2005, McDonald 2010 and Swanton criteria for prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis
155. MicroRNAs in clinically isolated syndrome
156. The Face-Symbol Test is a reliable surrogate for the Paced Auditory Serial Addition Test in both clinically Isolated syndrome and multiple sclerosis
157. THE RELATIONSHIP BETWEEN BLOOD CYTOKINE LEVEL AND PHYSICAL-MENTAL FATIGUE IN PATIENTS WITH MYASTHENIA GRAVIS
158. Effects of childbearing issues on prognosis in patients with multiple sclerosis
159. Utilization of the brief international cognitive assessment for multiple sclerosis during treatment of relapses in patients with multiple sclerosis
160. Premenstrual worsening in multiple sclerosis: physical disability and cognitive decline
161. Fatigue in menstrual cycle: comparison of premenstrual period and ovulation phase in patients with multiple sclerosis
162. Correlation between magnetic resonance imaging lesions and intrathecal immunoglobulin synthesis in patients with multiple sclerosis
163. Possible predictive parameters to converse multiple sclerosis in patients with clinically isolated syndrome
164. The correlations between the cerebrospinal fluid tau levels, immunological parameters of the cerebrospinal fluid and the magnetic resonance imaging findings in patients with multiple sclerosis in an attack period
165. Optic coherence tomography in cases with optic neuritis
166. Exercise perception in patients with multiple sclerosis based on disability level
167. Childhood onset multiple sclerosis has worse prognosis than adult onset MS on the basis of cognition and magnetic resonance imaging findings
168. Comparison of childhood and juvenile onset multiple sclerosis with adult onset MS concerning clinical and magnetic resonance imaging findings
169. A case report of hereditary spastic paraplegia with thin corpus callosum
170. Clinic neuroophtalmologic, clectrophysiologic and imaging methods in optic neuritis diagnosis
171. Development of multiple sclerosis after vaccination against hepatitis B: a prospective study based on clinical and MR1 features and HLA haplotypes
172. Two cases with clinically isolated conus medullaris syndrome
173. Importance of oligoclonal banding in multiple sclerosis: relation with demographic, clinical features and genetic background
174. The association of human leukocyte antigens with disease severity and prognosis in patients with multiple sclerosis
175. Utilisation of multiple sclerosis functional composite in multiple sclerosis: 5-year follow-up
176. The demographic and clinical features of familial multiple sclerosis: Comparison with sporadic MS
177. Do MS-specific quality of life instruments improve measurement on the basis of multiple sclerosis functional composite in MS patients?
178. Fatigue and its associations with disability and sociodemographic variables in patients with multiple sclerosis: variations between relapse and remission period
179. Comparison of McDonald 2005, McDonald 2010 and Swanton criteria for prediction of conversion from clinically isolated syndrome to multiple sclerosis
180. Pattern of cognitive impairment and related factors in clinically isolated syndrome
181. Movement disorders in demyelinating diseases
182. Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test
183. Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features
184. Clinical and therapeutic predictors of relapse and disability outcomes in neuromyelitis optica spectrum disorder
185. Determinants of MS re-activation after discontinuing therapies
186. Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models
187. Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis
188. Aggressive form of multiple sclerosis can be predicted early after disease onset
189. Balo's concentric sclerosis in a Turkish patient: a serial MRI and MRS study
190. Determinants of therapeutic lag in relapsing multiple sclerosis
191. Risk of secondary progressive multiple sclerosis: a longitudinal study
192. Disability accrual in primary-progressive & secondary-progressive multiple sclerosis
193. Comparison of the effectiveness of ocrelizumab vs interferons, fingolimod and natalizumab on relapses in relapsing-remitting multiple sclerosis
194. Early clinical predictors of severe MS
195. Multiple Sclerosis Severity Score (MSSS) helps predict relapses and recovery from disability in patients treated for multiple sclerosis in the MSBase model
196. MS cohorts and treatment utilization in academic centres in the Middle East
197. High and low efficacy therapy in secondary progressive multiple sclerosis after accounting for therapeutic lag
198. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
199. Diffusion tensor imaging evaluations of visual pathways in multiple sclerosis patients with acute and chronic optic neuritis
200. The concurrence of trigeminal and glossopharyngeal neuralgia in multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.